(14.25AE7.36 vs 8.24AE3.97) than those of normal weight men. Using the spearman correlation analysis, there was a significant negative correlation between BMI and serum T levels was found.
METHODS C57BL/6J mice exposure to left anterior descending coronary artery ligation were used as in vivo models. At the end of reperfusion, cardiac function was evaluated with echocardiography, the myocardial infarct size was determined by the Evans blue/2, 3, 5-triphenyltetrazolium chloride (TTC) double staining, myocardial apoptosis was detected by TUNEL staining and caspase-3 activity. (LV vol) [(40.33AE4.67 )ul vs (15.52AE3.47)ml, P < 0.05], decreased left ventricular ejection fractions (EF) [(30.9AE3 .2)% vs (72.4AE2.1)%, P < 0.05], and left ventricular fractional shortening (FS) [(15.1AE2 .0)% vs (40.7AE1.6)%, P < 0.05]; increased the myocardial infarct area (I/R,36.3% AE2.3% of AAR vs. sham, 0% of AAR, P < 0.05), TUNEL-positive myocytes [(20.0AE1.6 )% vs (1.0AE0.2)%, P < 0.05], and caspase-3 activity [(2.64AE0.4)% vs (1.00AE0.2)%, P < 0.05]. Compared to I/R group, sRAGE pre treatment significantly improved EF [(46.5AE2.0 There were rare TUNEL-positive nuclei both in sham and shamþsRAGE group (P > 0.05). There were no differences in LVAW, LVPW, LVID and LV vol between I/R and I/RþsRAGE groups.
RESULTS
CONCLUSIONS These results suggest that sRAGE protects against I/R induced-myocardial injury via inhibiting apoptosis. RESULTS Change in weight SDS between birth and 2 years was higher in BW-I group than in the BW-II group and BW-III group (P <0.05). Birth weight of the CU group was lower than that of the NC group and the CD group (P <0.05). Among the BW-Igroup, the proportion of subjects in the BW-I-CU group (61.76%) was higher than that in the non-BW-I-CU group (38.24%) (P <0.05). The body fat composition indexes (BMI, PBF and WtHR) were higher in the BW-III group than in the BW-I group and BW-II group (P <0.05). The body fat composition indexes were higher in the CU group than in the NC group and the CD group (P <0.05). In the CU group, the body fat composition indexes were higher in the BW-III-CU group than in the BW-I-CU group and BW-II-CU group (P <0.05).
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CONCLUSIONS Both lower birth weight individuals with more weight change-up growth in infancy and higher birth weight individuals had greater body fat composition in childhood. They were high-risk people of obesity. There is a need to develop public health policies that adopt preventive measures to prevent different birth weight individuals from fat mass accumulation postnatal early. Optimal life style during pregnancy and infancy is necessary to prevent from fat mass accumulation and further to prevent adult metabolic syndrome.
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Prospective study of antimicrobial prophylaxis for the prevention of surgical-site infections in 3 cardiac surgeries Caihong Qu, Xiaoyan Li, Zhenda Zheng, Jieming Zhu, Yongming Zhang The Third Affiliated Hospital of Sun Yat-sen University OBJECTIVES In order to provide practitioners with an approach to the rational, safe, and effective use of antibiotics for the prevention of surgicalsite infections (SSIs), study was carried out in 3 cardiac surgeries.
METHODS Information regarding patient-related factors associated with an increased risk of SSIs, use of antimicrobial agents for SSIs and development of incision infection during 2012w2014 in our hospital was collected and summarized in 3 cardiac surgeries, including permanent pacemaker implantation (90 cases), percutaneous coronary intervention (180 cases) and cardiac radiofrequency ablation (90 cases).
RESULTS After 3 years of effort of clinical pharmacists collaborating with the medical team, the ratio of prophylactic use of antibiotics in 3 cardiac surgeries in our hospital decreased from 100% to 20% as a whole; the preoperative-dose timing is within 60 minutes before surgical incision; selection, dosing and duration of prophylaxis of antibiotics for SSIs were rational and in accord with the latest guidelines.
CONCLUSIONS Based on this study, antimicrobial prophylaxis may not be routine for percutaneous coronary intervention and cardiac radiofrequency ablation. However, antimicrobial prophylaxis is recommended for permanent pacemaker implantation, and the course of antimicrobial prophylaxis should be limited in 48h. First generation cephalosporins have been shown to be effective for the prevention of SSIs in patients without being colonized with methicillin resistant Staphylococcus aureus.
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The role of mutant Plzf in metabolic and hemodynamic disturbances in spontaneously hypertensive rats RESULTS SHR-Plzf þ/-versus SHR wild type controls exhibited reduced body weight and relative weight of epididymal fat, lower serum triglycerides and liver triglycerides, as well as lower serum cholesterol and liver cholesterol. In addition, SHR-Plzf þ/-rats exhibited significantly increased sensitivity of adipose and muscle tissue to insulin action when compared to wild type controls. The SHR-Plzf þ/-heterozygous rats vs. wild type controls showed significant amelioration of cardiomyocyte hypertrophy and fibrosis. Gene expression profiles revealed differential expression of genes with the role in cell cycle.
CONCLUSIONS These results provide evidence for important role of Plzf in regulation of metabolic and hemodynamic traits in the rat and suggest cross-talk between cell cycle regulators, metabolism, cardiac hypertrophy and fibrosis. METHODS First, we selected some symptoms and their relative common diseases. Second, we edited diagnostic key points (cause, exciting cause, clinical manifestation, past history, personal history and family history) into choice questions according to textbooks, guidelines and expertise, and stored them to the question database. And we stored diagnostic results (preliminary diagnosis, sign of disease, auxiliary examination and clinical departments to visit) to the answer database. Then we linked the two databases using metadata base technology through special logic rules. After that, we evaluated diagnostic value on coronary artery disease of the diagnostic system (symptom: chest pain) in cardiovascular department and diagnostic value on gastroduodenal ulcers as well as hypertension portal of the diagnostic system (symptom: hematemesis) in digestive system department.
GW26-e0388 Adult Common Diseases Computer Diagnostic System
RESULTS "Adult Common Diseases Computer Diagnostic System" consists of four main interfaces. They are symptom selection interface (choose one's own symptoms), symptomatic question interface (answer questions), diagnostic results interface (review diagnostic results), and sign and auxiliary examination interface (review sign and auxiliary examination). 1310 patients with chest pain in cardiovascular department were included. Among the total, 1025 patients underwent coronary angiography (CAG).
Compared with results of CAG for diagnosis of coronary artery disease, diagnostic value for system was a sensitivity of 85.1% and a specificity of 32.6%. Compared with clinical diagnosis, diagnostic value for system was a sensitivity of 76.4% and a specificity of 46.3% for angina pectoris; and a sensitivity of 58.1% and a specificity of 83.8% for myocardial infarction. 170 patients with hematemesis in digestive system department were included, 127 among them underwent gastroscope. Compared with results of gastroscope for diagnosis of gastroduodenal ulcer, diagnostic value for system was a sensitivity of 50% and a specificity of 85.9%. Compared with clinical diagnosis for portal hypertension, diagnostic value for system was a sensitivity of 54.3% and a specificity of 90.8%.
CONCLUSIONS We succeed to create "Adult Common Diseases Computer Diagnostic System". In view of preliminary clinical evaluation, the system had a good clinical diagnostic value for being widely used.
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Myocardial ischemia due to pegylated interferon alpha-2a treatment in a patient with chronic hepatitis B Caihong Qu, Zhenda Zheng, Xiaoyan Li, Jieming Zhu The Third Affiliated Hospital of Sun Yat-sen University OBJECTIVES Many undesirable effects may appear during interferon alpha treatment for chronic hepatitis B. However, only a few cardiovascular adverse effects associated with interferon alpha have been reported. This paper provides a rare case report regarding cardiac toxicity of interferon alpha for chronic hepatitis B treatment.
METHODS After 4 months of pegylated interferon alpha-2a treatment, a 38-year-old male patient with chronic viral hepatitis B developed mild chest tightness and chest pain accompanied by nausea, vomiting. Dynamic electrocardiogram showed paroxysmal tachycardia and abnormal ST-T (T wave inversion).
RESULTS After withdrawal of interferon alpha, symptoms such as chest tightness, chest pain and T wave inversion were gradually relieved. The patient had no history of coronary heart disease before medication, so myocardial ischemia due to interferon alpha-2a treatment was considered.
CONCLUSIONS Although interferon-induced myocardial ischemia is rare, it is still likely to develop into fatal danger, if not diagnosed and treated timely. Prescribers should be alert to the possibility of this severe adverse drug reaction associated with interferon use.
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Impact of blood glucose variability on cardiac structure and function in patients with type 2 diabetes mellitus 3 Department of Cardiology, the Third Affiliated Hospital, Sun Yat-sen University, Tian-he Road, Guangzhou 510630, China OBJECTIVES Hyperglycemia is a risk factor for cardiovascular disease. However, the relationship between blood glucose variability and cardiac structure and function remains unclear. The present study aimed to explore the impact of glucose variability on cardiac structure and function in patients with type 2 diabetes mellitus (T2DM).
METHODS According to glucose variability, which was assessed by mean amplitude of glycemic excursions (MAGE), 63 consecutive type 2 diabetic patients under glycemic control without any coronary artery disease and hypertension were divided into two groups: subjects with non-glucose fluctuation (MAGE<3.9mmol/l, n¼31) and subjects with glucose fluctuation (MAGE!3.9mmol/l, n¼32). Thirty healthy controls (NC) were also enrolled. Myocardial structural and functional changes were evaluated by echocardiography including left ventricle end diastolic diameter (LVEDD), left ventricle end systolic diameter (LVESD), left ventricle end diastolic volume (LVEDV), left ventricular end systolic volume (LVESV), interventricular septal thickness (IVST), left ventricular posterior wall thickness (LVPW), ejection fraction (EF), Mitral E wave, Mitral A wave, E/A ratio, and Tei index.
RESULTS LVESD, LVESV, IVST, LVPW and LVEF had no significant differences among all groups (p<0.05). However, when compared to nonglucose fluctuation subjects and NC group, LVEDD (51.12AE4.92mm vs. 46.14AE4.65mm vs. 45.32AE3.37mm, p<0.05) and LVEDV (101.32AE4.93mm vs. 87.83AE6.19mm vs. 90.51AE5.34mm, p<0 .05) were significant higher in patients with glucose fluctuation, while E/A ratio was significant lower (0.77AE0.38 vs. 0.98AE0.46 vs. 1.28AE0.23, p<0.05). Furthermore, the Tei index was higher in T2DM patients than that in NC group (0.49AE0.1, 0.40AE0.05, p<0.05, respectively), and was further increase in T2DM patients with glucose fluctuation than that in patients with non-glucose fluctuation (0.52AE0.01 vs 0.48AE0.11, p<0.05).
CONCLUSIONS Blood glucose variability might impair myocardial performances of T2DM patients, especially for diastolic function, which contributes to the risk of cardiomyopathy among diabetic individuals.
